
Zydus Lifesciences has launched VaxiFlu, India’s first trivalent influenza vaccine for seasonal flu protection. The vaccine follows WHO’s 2025–26 guidelines…
Nuvama on Divi’s Laboratories: Nuvama projects a 15% upside for Divi’s Laboratories; discover the three reasons behind this pharma stock’s…
Jefferies names Sai Life, Divi’s, and Cohance as top Indian CRDMO picks with up to 37% upside—see which pharma stocks…
Investors are increasingly turning to ‘safer’ MNC pharma stocks with a domestic focus at a time when the Trump administration…
Sun Pharma slides 6% after weak Q1 FY26 results, but Motilal Oswal still recommends Buy—discover the three reasons to consider…
Jubilant Pharmova reported a 78.66 per cent decline in Q1 profit due to a high base effect, even as revenue…
Despite US tariff concerns, India’s pharmaceutical exports are projected to double to $65 billion by 2030. This growth is fueled…
Once the regulator’s guidance is accepted by the European Commission, the authorisation is valid in all 27 EU member countries…
Cipla reports 10 per cent rise in net profit to Rs 1,298 crore for Q1FY26 with India business crossing Rs…
He emphasised a grace period of roughly one year for drug companies to adjust before facing steep tariffs.
Donald Trump’s proposal of up to 200% tariffs on pharmaceutical imports has put Indian drugmakers on high alert.
Sun Pharma is stepping up regulatory compliance efforts at three USFDA-flagged facilities, including Halol, Mohali, and Dadra.
Worries about further hiccups in the potential trade deal and consequent higher tariffs between India and the United States are…
One of the most widely followed investors and a Warren Buffett of India, Ashish Kacholia, is doing it again. He…
On the drug approvals, Dr Rajeev Singh Raghuvanshi, the DCGI, highlighted innovative therapies that were both impactful in terms of…
At the FE Healthcare Summit & Awards 2025, DCGI Rajeev Singh Raghuvanshi emphasized the need for the Indian pharma sector…
Lupin has received USFDA approval for its ANDA for Prucalopride Tablets, used to treat Chronic Idiopathic Constipation in adults.
Explore Goldman Sachs’ top 5 Indian pharma stock picks with up to 36% upside – see the full recommendations now!